170 results on '"Welte Tobias"'
Search Results
2. Clinical factors linked to the type of respiratory medication in COPD: Results from COSYCONET
3. The bronchiectasis exacerbation definition in a real-world setting: data from the EMBARC registry
4. The microbiology of bronchiectasis in Europe: Data from the European Bronchiectasis Registry (EMBARC)
5. Proteinase 3 as a marker of clinical severity in bronchiectasis: Data from the EMBARC-BRIDGE study
6. Effects of patient serum containing different profiles and magnitudes of inflammatory markers on human microvascular lung endothelial and bronchial epithelial cells
7. Sputum colour assessment and clinical outcomes in bronchiectasis: data from the EMBARC Registry
8. Pseudomonas aeruginosa eradication in patients with bronchiectasis: data from the EMBARC registry
9. Late Breaking Abstract - Diversity of endothelial cells in restrictive allograft syndrome
10. Increasing CRPM levels following antifibrotic therapy in IPF is associated with adverse outcomes with nintedanib, but not pirfenidone
11. Treatment with low-molecular-weight heparin negatively effects lung cancer patient survival
12. Vilobelimab’s effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT
13. “Super Survivor” after Lung Transplantation – Protective Role of Macrophages?
14. Morphomolecular analysis of the capillary network in alveolar capillary dysplasia
15. Alpha-1 antitrypsin deficiency genotypes in a large international cohort study of bronchiectasis (EMBARC BRIDGE)
16. Convergent validity of the Bronchiectasis Impact Measure: data from the EMBARC-BRIDGE study
17. Validation of the Rose Criteria for COPD-Bronchiectasis Overlap: Data from the European Bronchiectasis Registry (EMBARC)
18. Neutrophil metabolomics in bronchiectasis: data from the EMBARC BRIDGE study
19. Blood eosinophils, inhaled corticosteroids and exacerbations in bronchiectasis: Data from the EMBARC registry
20. Characteristics and outcomes of adults with primary ciliary dyskinesia (PCD): an EMBARC/BEAT-PCD analysis
21. Clinical decision making is improved by rapid multiplex-PCR in suspected lower respiratory tract infection after lung transplantation in a prospective cohort study
22. Late Breaking Abstract - Role of matrix metalloproteinase-2 and -9 in experimental lung fibrosis in mice
23. The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry
24. Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry
25. The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry
26. Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
27. Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
28. COPD maintenance therapy is related to left heart size: Results from the multicenter long-term observation COSYCONET
29. Does acute phase protein alpha1-antitrypsin modulate apoptosis-autophagy crosstalk resulting in resistance of NSCLC cells to cancer drugs?
30. Treatment with inhaled corticosteroids in COPD groups GOLD A and B –relationship to clinical state in the COSYCONET cohort
31. A specific monoclonal antibody targeting C-36 peptide of alpha1-antitrypsin as a tool in respiratory research
32. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
33. The NLRP3-inflammasome-caspase-1 pathway is upregulated in idiopathic pulmonary fibrosis and acute exacerbations and is inducible by apoptotic A549 cells
34. Characterisation of eosinophilic bronchiectasis: A European multicohort study
35. Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
36. Lipid-related anti-cancer drug resistance of lung adenocarcinoma cells
37. Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
38. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
39. Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET
40. 3D PREFUL: Novel high resolution dynamic lung ventilation imaging in patients with asthma, cystic fibrosis and COPD and healthy volunteers
41. Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry
42. Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study
43. Comparative transcriptomic profiling of CD4+ T cells in two models of lung fibrosis in mice
44. Prediction of lung hyperinflation by forced spirometry: Results from COSYCONET
45. Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS
46. Role of regulatory T cells in S. pneumoniae-induced exacerbation of lung fibrosis in mice
47. Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study
48. Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC)
49. Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC
50. Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.